Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor.
AUTOR(ES)
Morgan, J
RESUMO
To study the effect of T-cell-derived BCGF-12kD on human B-cell autocrine growth-associated functions, we cultured Epstein Barr virus (EBV)-transformed normal B cells (LCL 72285) and Burkitt's lymphoma cells (Raji) in the presence or absence of BCGF-12kD. When cultured in media supplemented only with fetal calf serum, the LCL and Raji cell lines maintained relatively high levels of episomes. Although a similar level of proliferation could be maintained under defined culture conditions in media supplemented with BCGF-12kD, these conditions resulted in a time-dependent reduction of EBV sequences, as detected with EBV nuclear antigen (EBNA-1 and EBNA-2) gene probes. These results suggest that stimulation with T-cell-derived BCGF-12kD can alter a regulatory step which may be involved in the EBV transformation of B cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=250881Documentos Relacionados
- Synergistic activation of cells by Epstein-Barr virus and B-cell growth factor.
- Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.
- Prevention of Epstein-Barr virus-induced B-cell outgrowth by interferon alpha.
- Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas
- Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.
